Bb Biotech AG BB BIOTECH ORD SHS
Bb Biotech AG BB BIOTECH ORD SHS/ CH0038389992 /
0JYO
18/10/2024 13:37:34
|
Chg.
+0.12
|
Volume |
Bid17:40:03 |
Ask17:40:03 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
37.35CHF
|
+0.32%
|
842 Turnover: 31,448.20 |
-Bid Size: - |
-Ask Size: - |
2.07 bill.CHF |
5.35% |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
-3.77 CHF |
-42.00% |
EPS Diluted: |
- CHF |
-42.00% |
Revenues per Share: |
0.01 CHF |
-57.94% |
Book Value per Share: |
41.94 CHF |
-13.51% |
Cash Flow per Share: |
3.94 CHF |
-5.56% |
Dividend per Share: |
2.00 CHF |
-29.82% |
Total |
in mill. |
|
Revenues: |
0.53 CHF |
-57.94% |
Net Income: |
-206.61 CHF |
-42.26% |
Operating Cash Flow: |
218.28 CHF |
- |
Cash and Cash Equivalents: |
0.50 CHF |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
- |
- |
P/S Ratio: |
3,904.13 |
4,468.58 |
P/BV ratio: |
0.89 |
1.02 |
P/CF Ratio: |
9.48 |
10.85 |
PEG: |
0.24 |
- |
Earnings Yield: |
-10.09% |
-8.82% |
Dividend Yield: |
5.35% |
4.68% |
Market Capitalization |
|
Market Capitalization: |
2.07 bill. CHF |
2.37 bill. CHF |
Free Float Market Cap.: |
- CHF |
- CHF |
Market Cap. / Employee: |
22.01 mill. CHF |
25.2 mill. CHF |
Shares Outstanding: |
55.4 mill. |
|
Profitability
Gross Profit Margin: |
- |
EBIT Margin: |
0.00% |
Net Profit Margin: |
-38,982.45% |
Return on Equity: |
-8.89% |
Return on Assets: |
-7.83% |
Financial Strength
Liquidity I / Cash Ratio: |
- |
Liquidity II / Quick Ratio: |
- |
Liquidity III / Current Ratio: |
- |
Debt / Equity Ratio: |
13.51% |
Dynam. Debt / Equity Ratio: |
143.83% |
Efficiency
Employees: |
94 |
Personal Expenses / Employee: |
- CHF |
Revenues / Employee: |
5,638.30 CHF |
Net Income / Employee: |
-2,197,946.81 CHF |
Total Assets / Employee: |
28,054,829.79 CHF |
* Fiscal Year End: |
31/12/2023 |
Accounting Standard: |
IFRS |